UKCPA Education Groups All Groups

Respiratory Group

The UKCPA Respiratory Committee is committed to improving the care of respiratory patients through education of clinical pharmacists and influencing practice more widely.

Follow this group

Ravijyot Saggu


Senior Clinical Pharmacist & Emergency Services and Medicines and Respiratory Link,

University College Hospital NHS Foundation Trust

Patrick Wilson


Lead Pharmacist High Cost Medicines Management,

Nottingham University Hospitals

Helen Edwards

Education Lead

Medicines Information and Formulary Pharmacist

NHS Arden and Greater East Midlands Commissioning Support Unit

Dr Helen Meynell

Membership Lead

Consultant Pharmacist,

Doncaster & Bassetlaw Hospitals NHS Foundation Trust

Sarah Poole

Membership Lead

Lead Respiratory Pharmacist,

Oxford University Hospitals NHS Foundation Trust

Anna Murphy

Standards & Consultations Lead

Consultant Pharmacist,

University Hospitals Leicester

Grainne D’Ancona

Severe asthma Sub-Committee Lead

Consultant Pharmacist,

Guy’s and St Thomas’ NHS Foundation Trust

RPS Accredited Training Provider

The UKCPA Respiratory Group is committed to improving the care of respiratory patients



They regularly run UKCPA learning events for clinical practitioners, speak at national and international conferences, and represent the profession in the media.

The Committee has successfully advised the pharmaceutical industry on how patients use respiratory medicines, and have provided expertise which has influenced national guidelines.

Activity highlights

The Committee led on and co-ordinated a multi-organisational approach to advise GlaxoSmithKline to change the colour of Relvar Ellipta® from blue to yellow. The advice, in collaboration with the Association of Respiratory Nurse Specialists, Asthma UK, British Lung Foundation, British Thoracic Society, Education for Health, Primary Care Respiratory Society, Respiratory Education UK, and the Royal Pharmaceutical Society, highlighted concerns around the association of the colour blue as a reliever inhaler, and the similarity of the Relvar® brand name to the term “reliever”, which could cause confusion and lead to prescribing errors or for patients to take additional doses during the day. GSK welcomed the advice and the colour of the inhaler was changed.

The UKCPA Respiratory Committee were the also first organisation to publicly advise that inhaled medicines should be prescribed by brand name to ensure that patients receive the correct inhaler device and prevent inadvertent device switches. The Committee worked with the UK Inhaler Group to reinforce this position. As a result, the British Thoracic Society / SIGN Asthma 2016 guidelines made a good practice recommendation stating that “Generic prescribing of inhalers should be avoided as this might lead to people with asthma being given an unfamiliar inhaler device which they are not able to use properly.”

Get involved

We have plenty of opportunities for you to get involved in the UKCPA Respiratory Group:

  • Speakers and tutors for respiratory learning events, including conference workshops, masterclasses and webinars
  • Practitioners who have a flair for writing to produce articles for the UKCPA newsletter and website
  • Practitioners who can comment on national consultations
  • Joining the UKCPA Respiratory Group committee


If you would like to know more about the Respiratory Committee, or would like to get involved in their activities, please contact the Chair, Ravijyot Saggu

Become a member

Joining UKCPA is easy with a range of payment options to suit you. Join today and start enjoying the benefits immediately.